Bortezomib after allografting in multiple myeloma: association between neurotoxicity and cyclosporine treatment

Biol Blood Marrow Transplant. 2007 Apr;13(4):497-9. doi: 10.1016/j.bbmt.2007.01.069.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Boronic Acids / adverse effects*
  • Bortezomib
  • Cyclosporine / adverse effects*
  • Drug Interactions
  • Humans
  • Immunosuppressive Agents / adverse effects*
  • Multiple Myeloma / therapy*
  • Neoplasm Recurrence, Local / drug therapy*
  • Peripheral Nervous System Diseases / chemically induced
  • Pyrazines / adverse effects*
  • Transplantation, Homologous

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Immunosuppressive Agents
  • Pyrazines
  • Bortezomib
  • Cyclosporine